Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
79.90
+2.24 (2.88%)
Oct 27, 2026, 4:00 PM EDT - Market closed
Disc Medicine Employees
Disc Medicine had 165 employees as of June 30, 2026. The number of employees increased by 40 or 32.00% compared to the same quarter last year. That makes Disc Medicine the 28,132nd largest employer in the world and 3,559th in the United States.
Employees
165
Change (1Y)
40
Growth (1Y)
32.00%
Revenue / Employee
n/a
Profits / Employee
-$1,490,230
Market Cap
3.55B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 165 | 40 | 32.00% | 165 | 0 |
| Mar 31, 2026 | 154 | 60 | 63.83% | 154 | 0 |
| Dec 31, 2025 | 155 | 71 | 84.52% | 155 | 0 |
| Sep 30, 2025 | 142 | 60 | 73.17% | 142 | 0 |
| Jun 30, 2025 | 125 | 47 | 60.26% | 125 | 0 |
| Mar 31, 2025 | 94 | 16 | 20.51% | 94 | 0 |
| Dec 31, 2024 | 84 | 10 | 13.51% | 84 | 0 |
| Sep 30, 2024 | 82 | 22 | 36.67% | 82 | 0 |
| Jun 30, 2024 | 78 | 23 | 41.82% | 78 | 0 |
| Mar 31, 2024 | 78 | 27 | 52.94% | 78 | 0 |
| Dec 31, 2023 | 74 | 28 | 60.87% | 74 | 0 |
| Sep 30, 2023 | 60 | 22 | 57.89% | 60 | 0 |
| Jun 30, 2023 | 55 | 17 | 44.74% | 55 | 0 |
| Mar 31, 2023 | 51 | 13 | 34.21% | 51 | 0 |
| Dec 31, 2022 | 46 | - | - | 46 | 0 |
| Jun 30, 2022 | 38 | - | - | 37 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Telix Pharmaceuticals | 1,184 |
| Acadia Pharmaceuticals | 798 |
| AbCellera Biologics | 562 |
| Xenon Pharmaceuticals | 370 |
| Tarsus Pharmaceuticals | 370 |
| Celcuity | 155 |
| IDEAYA Biosciences | 145 |
IRON News
- 6 days ago - Disc Medicine price target raised to $110 from $100 at Wedbush - TheFly
- 7 days ago - Disc Medicine 6M share Secondary priced at $75.00 - TheFly
- 7 days ago - Disc Medicine Announces Pricing of $450 Million Upsized Public Offering of Common Stock - GlobeNewsWire
- 7 days ago - Disc Medicine price target raised to $115 from $83 at Truist - TheFly
- 7 days ago - Disc Medicine price target raised to $92 from $90 at Morgan Stanley - TheFly
- 7 days ago - Disc Medicine price target raised to $170 from $125 at Cantor Fitzgerald - TheFly
- 7 days ago - Disc Medicine price target raised to $124 from $86 at Wells Fargo - TheFly
- 8 days ago - Disc Medicine announces $350M common stock, warrants offering - TheFly